• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home News & Updates Page 2

News & Updates

Stay up to date with new data, maps, infographics, blog posts, and other educational resources to help you better understand the viral hepatitis epidemic in the U.S. and its intersection with the opioid epidemic.

Categories:

Toolkits Awareness Days What's New in Viral Hepatitis Hep A Hep B Hep C Opioids COVID-19

April 14, 2025

What's New in Viral Hepatitis - April 2025

February 20, 2025

What's New in Viral Hepatitis - February 2025

Read More

December 11, 2024

What's New in Viral Hepatitis - December 2024

Read More

November 21, 2024

World Hepatitis Testing Week 2024 Toolkit

Read More

October 24, 2024

What's New in Viral Hepatitis - October 2024

Read More

August 23, 2024

HepVu’s One Question Series on Viral Hepatitis Elimination: RNA HCV Testing

Read More

August 23, 2024

What's New in Viral Hepatitis - August 2024

Read More

July 23, 2024

Announcing the 2024-2025 Vu Fellowship

Read More

July 18, 2024

New Hepatitis C Prevalence Updates Webinar

Read More

June 27, 2024

CBO Report: Budgetary Effects of Policies That Would Increase Hepatitis C Treatment

  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4
  • Interim pages omitted …
  • Go to page 19

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.